A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

PHASE3CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Herpes Zoster

Interventions

BIOLOGICAL

zoster vaccine live (ZOSTAVAX™)

1 dose 0.65 mL/dose subcutaneous injection of zoster vaccine live

BIOLOGICAL

Comparator: Placebo

1 dose 0.65 mL/dose subcutaneous injection of placebo.

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00322231 - A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014) | Biotech Hunter | Biotech Hunter